Rob Lutz, Founder & Editorial Director 
Apolipoprotein B (ApoB) is a crucial structural protein found in atherogenic lipoproteins, including low-density lipoprotein (LDL), very low-density lipoprotein (VLDL), intermediate-density lipoprotein (IDL), and lipoprotein(a) [Lp(a)]. Unlike other lipid markers such as LDL-C, which measure cholesterol content, ApoB provides a direct count of the number of atherogenic lipoprotein particles, makingRead
Nicotinamide adenine dinucleotide (NAD) is a key cellular component in virtually all forms of life. While best known for its major role in energy metabolism, NAD is also essential in many signaling pathways. As a result, many NAD-dependent proteins involved in signaling reactions serve as metabolic sensors in the cellRead
Advanced lipid testing goes beyond traditional cholesterol panels, providing detailed insights into cardiovascular risk factors like Lp(a), apoB, and LDL-P. Discover how these tests support risk stratification, personalized treatments, and improved patient outcomes.
Lipoprotein(a), abbreviated as LP(a), is a unique lipoprotein particle that has garnered increasing attention in recent years due to its significant role in cardiovascular health. As an emerging biomarker, LP(a) is now recognized as a crucial factor in assessing a patient’s risk for atherosclerosis, coronary artery disease (CAD), and otherRead
In this episode of the OneMedicine Podcast, we discuss the impact of poor sleep on overall health with a specific focus on pain. Chris reviews the biochemistry and offers ways to help your patients disrupt this feedback loop and get their sleep and health back on track. CLICK TO LISTENRead
Modified Citrus Pectin Blocks Gal-3 to Protect Against Post-Stroke Brain Injury A growing body of data points to microglial neuroinflammation as a contributing factor in ischemic stroke injury — driven by high levels of galectin-3 (Gal-3), a master proinflammatory alarmin protein. Research shows that Gal-3 promotes unregulated microglial activation andRead
Curcumin and the Blood Brain Barrier: Neuroprotective effect of turmeric extract in combination with its essential oil and enhanced brain bioavailability in an animal model. Banji D, Banji OJ, Srinivas K. BioMed Res Int. 2021; (January): 1-12 PURPOSE: The study evaluated the neuroprotective effect and pharmacokinetic profile of turmeric extractRead
There’s no doubt that we need to drastically improve our health. The fact that 60 percent of Americans are taking some kind of prescription drug should set off alarms in everyone. Synthetic medicines typically create more problems than they claim to solve. They are “one track” solutions to problems thatRead
Cognitive impairment and the development of Alzheimer’s disease are recognized risk factors in type 2 diabetes mellitus. Research continues to link metabolic dysregulation and specifically, insulin resistance, with Alzheimer’s disease and other forms of cognitive loss. Galectin-3 Fuels Diabetes and Cognitive Decline Emerging research into the beta-galactoside binding protein Galectin-3 (Gal-3) offersRead
In this episode of the OneMedicine Podcast, featuring Dr Mark Houston, we discuss dyslipidemia including common misconceptions, suggested testing, and an overview of the highly personalized approach he recommends for successful outcomes. “Precision and personalized cardiovascular medicine must be the new medicine of today and the future,” says Mark Houston,Read
Weekly round-up, access to thought leaders, and articles to help you improve health outcomes and the success of your practice.
